Oida et al. first identified a new regulatory CD4+ T cell phenotype that is CD25− and LAP+, and they found that CD4+LAP+ CD25− T cells could effectively ameliorate CD4+CD45RBhigh-induced colitis by a TGF-β-dependent mechanism [17]. This evidence concerns the gene CD4 and colitis.